BBT structure
|
Common Name | BBT | ||
---|---|---|---|---|
CAS Number | 445000-45-3 | Molecular Weight | 386.26 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C18H12BrNO2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of BBTBBT is an enhancer of impaired glucose-stimulated insulin secretion (GSIS). BBT exhibits anti-hyperglycemia activity, and protects β-cells from cytokine- or streptozotocin (STZ)-induced cell death in type 2 diabetes models. BBT acts function via cAMP/PKA and long-lasting (L-type) voltage-dependent Ca2+ channel/CaMK2 pathway[1]. |
Name | BBT |
---|
Description | BBT is an enhancer of impaired glucose-stimulated insulin secretion (GSIS). BBT exhibits anti-hyperglycemia activity, and protects β-cells from cytokine- or streptozotocin (STZ)-induced cell death in type 2 diabetes models. BBT acts function via cAMP/PKA and long-lasting (L-type) voltage-dependent Ca2+ channel/CaMK2 pathway[1]. |
---|---|
Related Catalog | |
Target |
L-type voltage-dependent Ca2+ channel/CaMK2[1] |
References |
Molecular Formula | C18H12BrNO2S |
---|---|
Molecular Weight | 386.26 |